Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity (Q33183439)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity |
scientific article |
Statements
1 reference
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity (English)
1 reference
Alex Sparreboom
1 reference
Jaap Verweij
1 reference
Harry J Groen
1 reference
Diederik F S Kehrer
1 reference
Annelies M Bos
1 reference
Walter J Loos
1 reference
Maja J A de Jonge
1 reference
Marta Hamilton
1 reference
Terri Cameron
1 reference
Elisabeth G E de Vries
1 reference
1 March 2002
1 reference
1 reference
20
1 reference
1222-1231
1 reference
Identifiers
1 reference
1 reference